BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
80 hedge funds and large institutions have $115M invested in BRAINSTORM CELL THERAPUTC in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 1.41% → 1.44% (+0.03%)
53% less call options, than puts
Call options by funds: $17.6M | Put options by funds: $37.8M
Holders
80
Holding in Top 10
–
Calls
$17.6M
Puts
$37.8M
Top Buyers
| 1 | +$6.24M | |
| 2 | +$4.03M | |
| 3 | +$1.48M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$1.45M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.09M |
Top Sellers
| 1 | -$2.61M | |
| 2 | -$1.58M | |
| 3 | -$1.11M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$579K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$430K |